These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
769 related articles for article (PubMed ID: 9260993)
1. Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. K-Laflamme A; Oster L; Cardinal R; de Champlain J Hypertension; 1997 Aug; 30(2 Pt 1):278-87. PubMed ID: 9260993 [TBL] [Abstract][Full Text] [Related]
2. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats. Foucart S; Patrick SK; Oster L; de Champlain J Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708 [TBL] [Abstract][Full Text] [Related]
3. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system. K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419 [TBL] [Abstract][Full Text] [Related]
4. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats. Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634 [TBL] [Abstract][Full Text] [Related]
5. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats. Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995 [TBL] [Abstract][Full Text] [Related]
6. Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats. Girouard H; Chulak C; LeJossec M; Lamontagne D; de Champlain J J Hypertens; 2003 Jan; 21(1):179-88. PubMed ID: 12544450 [TBL] [Abstract][Full Text] [Related]
7. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats. Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380 [TBL] [Abstract][Full Text] [Related]
8. Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: effects of losartan. Radhakrishnan R; Sim MK Eur J Pharmacol; 1994 Jun; 259(1):87-90. PubMed ID: 7957599 [TBL] [Abstract][Full Text] [Related]
9. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats. Chauvin B; Richer C; Giudicelli JF Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253 [TBL] [Abstract][Full Text] [Related]
10. Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow. Caputo L; Tedgui A; Lévy BI Circ Res; 1995 Aug; 77(2):303-9. PubMed ID: 7614717 [TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats. Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566 [TBL] [Abstract][Full Text] [Related]
12. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats. Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285 [TBL] [Abstract][Full Text] [Related]
13. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. Oddie CJ; Dilley RJ; Kanellakis P; Bobik A J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190 [TBL] [Abstract][Full Text] [Related]
14. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. Paull JR; Widdop RE J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847 [TBL] [Abstract][Full Text] [Related]
15. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Pu Q; Larouche I; Schiffrin EL Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331 [TBL] [Abstract][Full Text] [Related]
16. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats. Haws RM; Shaul PW; Arant BS; Atiyeh BA; Seikaly MG Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816 [TBL] [Abstract][Full Text] [Related]
17. The renin angiotensin system and nociception in spontaneously hypertensive rats. Irvine RJ; White JM; Head RJ Life Sci; 1995 Feb; 56(13):1073-8. PubMed ID: 9001440 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats. De Godoy MA; Rattan S J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368 [TBL] [Abstract][Full Text] [Related]
19. Supersensitivity of beta-adrenoceptor coupled adenylate cyclase in pulmonary tissue of the spontaneously hypertensive rat. Kamibayashi C; Ramanathan S Life Sci; 1989; 45(22):2115-25. PubMed ID: 2557517 [TBL] [Abstract][Full Text] [Related]
20. Effect of beta-adrenoceptor antagonist and angiotensin-converting enzyme inhibitor on hypertension-associated changes in adenylyl cyclase type V messenger RNA expression in spontaneously hypertensive rats. Fujino T; Hasebe N; Kawabe J; Fujita M; Fukuzawa J; Tobise K; Kikuchi K J Cardiovasc Pharmacol; 2003 May; 41(5):720-5. PubMed ID: 12717102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]